Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
OPXA [NASD]
Opexa Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.06 Insider Own0.80% Shs Outstand27.77M Perf Week-4.58%
Market Cap40.54M Forward P/E- EPS next Y-0.48 Insider Trans86.44% Shs Float25.36M Perf Month-7.59%
Income-16.10M PEG- EPS next Q-0.13 Inst Own6.00% Short Float3.35% Perf Quarter0.69%
Sales1.40M P/S28.96 EPS this Y18.80% Inst Trans-2.57% Short Ratio4.86 Perf Half Y-16.09%
Book/sh0.63 P/B2.32 EPS next Y4.00% ROA-80.60% Target Price5.00 Perf Year6.57%
Cash/sh0.71 P/C2.06 EPS next 5Y- ROE-115.70% 52W Range1.26 - 2.56 Perf YTD-19.78%
Dividend- P/FCF- EPS past 5Y22.60% ROI-69.90% 52W High-42.97% Beta2.38
Dividend %- Quick Ratio6.20 Sales past 5Y- Gross Margin- 52W Low15.87% ATR0.08
Employees38 Current Ratio6.40 Sales Q/Q50.00% Oper. Margin- RSI (14)41.74 Volatility5.15% 5.10%
OptionableNo Debt/Eq0.00 EPS Q/Q77.60% Profit Margin- Rel Volume0.76 Prev Close1.46
ShortableYes LT Debt/Eq0.00 EarningsNov 11 Payout- Avg Volume174.80K Price1.46
Recom2.00 SMA20-3.82% SMA50-7.71% SMA200-15.50% Volume132,329 Change0.00%
30-May-14Initiated Aegis Capital Buy $4
30-Mar-10Initiated Rodman & Renshaw Mkt Outperform $6
20-Feb-07Initiated MDB Capital Group Buy $8
14-Aug-14 04:23PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure EDGAR Online
04:05PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Opexa Therapeutics Reports Second Quarter 2014 Financial Results and Provides Corporate Update Business Wire
11-Aug-14 09:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2014 Financial Results Business Wire
17-Jul-14 10:58AM  RedChip Issues Research Profile on Opexa Therapeutics GlobeNewswire
08-Jul-14 11:30AM  RedChip's July 16-17 Global Online CEO Conference Presentation Schedule Now Available GlobeNewswire
30-Jun-14 08:00AM  Opexa Therapeutics Joins Russell Microcap Index Business Wire
26-Jun-14 09:25AM  RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg GlobeNewswire
09:25AM  RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
25-Jun-14 04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
03-Jun-14 09:24AM  Opexa Is Personalizing The Treatment Of Autoimmune Disease at Seeking Alpha
09:24AM  Opexa Is Personalizing The Treatment Of Autoimmune Disease
30-May-14 09:05AM  Coverage initiated on Opexa Therapeutics by Aegis Capital Briefing.com
09:05AM  Coverage initiated on Opexa Therapeutics by Aegis Capital
29-May-14 08:37AM  RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg GlobeNewswire +7.64%
08:37AM  RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
21-May-14 12:18PM  OPEXA THERAPEUTICS, INC. Financials EDGAR Online Financials
12:18PM  OPEXA THERAPEUTICS, INC. Financials
14-May-14 04:13PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure EDGAR Online
04:13PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure
04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  Opexa Therapeutics Reports First Quarter 2014 Financial Results and Provides Corporate Update Business Wire
04:01PM  Opexa Therapeutics Reports First Quarter 2014 Financial Results and Provides Corporate Update
13-May-14 08:04AM  Opexa Therapeutics reaches enrollment target in Phase IIb trial at theflyonthewall.com
08:04AM  Opexa Therapeutics reaches enrollment target in Phase IIb trial
08:03AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibit EDGAR Online
08:03AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibit
08:00AM  Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis Business Wire
08:00AM  Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
12-May-14 08:00AM  Opexa Therapeutics Announces News Release and Conference Call to Discuss First Quarter 2014 Financial Results Business Wire
30-Apr-14 09:00AM  Opexa Therapeutics: An Optimal Buyout Candidate Pending Successful Topline Results From Abili-T at Seeking Alpha +8.11%
22-Apr-14 08:00AM  Opexa Therapeutics to Attend the American Academy of Neurology Annual Meeting Business Wire
21-Apr-14 10:23AM  RedChip Global Online CEO Conference, April 23-24, Featuring Presentations From 30+ Small-Cap Companies GlobeNewswire +6.71%
10-Apr-14 10:18AM  RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg GlobeNewswire
24-Mar-14 06:02AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
21-Mar-14 08:00AM  Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa PR Newswire
20-Mar-14 08:01AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online
08:00AM  Opexa Therapeutics Appoints Prof. Hans-Peter Hartung and Timothy Barabe to the Board of Directors Business Wire
10-Mar-14 12:09PM  Opexa Therapeutics mentioned positively by Seeking Alpha contributor at theflyonthewall.com
12:09PM  Opexa Therapeutics mentioned positively by Seeking Alpha contributor
12:09PM  Opexa Therapeutics moves up on a positive Seeking Alpha blog at theflyonthewall.com
12:09PM  Opexa Therapeutics moves up on a positive Seeking Alpha blog
12:04PM  Opexa Therapeutics: A Long-Term Perspective For Price Appreciation at Seeking Alpha
12:04PM  Opexa Therapeutics: A Long-Term Perspective For Price Appreciation
07-Mar-14 01:04PM  OPEXA THERAPEUTICS, INC. Financials EDGAR Online Financials
05-Mar-14 04:48PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online
28-Feb-14 06:04AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
27-Feb-14 06:42PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
06:42PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report EDGAR Online
04:20PM  Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update Business Wire
04:20PM  Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update
26-Feb-14 08:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results Business Wire
08:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results
21-Feb-14 12:19PM  Will Opexa Become A Multi-Bagger? at Seeking Alpha
11-Feb-14 02:16PM  Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference Business Wire
29-Jan-14 09:00AM  Opexa Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference Business Wire
09:00AM  Opexa Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference
23-Jan-14 09:00AM  Opexa Therapeutics Chief Scientific Officer Invited as Guest Speaker at the Phacilitate Cell & Gene Therapy Forum Business Wire
09:00AM  Opexa Therapeutics Chief Scientific Officer Invited as Guest Speaker at the Phacilitate Cell & Gene Therapy Forum
07-Jan-14 07:30AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
07:30AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
23-Dec-13 10:29AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
10:29AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10:18AM  Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
10:18AM  Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
18-Dec-13 06:21AM  Opexa Therapeutics 4.12M share Spot Secondary priced at $1.70 theflyonthewall.com -10.64%
06:21AM  Opexa Therapeutics 4.12M share Spot Secondary priced at $1.70
06:06AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online
06:06AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh
17-Dec-13 09:15PM  Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock Business Wire
09:15PM  Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
04:38PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:38PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:33PM  Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock Business Wire
04:33PM  Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
16-Dec-13 08:05AM  Opexa Therapeutics provides update on Phase IIb trial theflyonthewall.com
08:05AM  Opexa Therapeutics provides update on Phase IIb trial
08:00AM  Opexa Therapeutics Provides MS Trial Enrollment Update; 70% of Patients Enrolled Business Wire
08:00AM  Opexa Therapeutics Provides MS Trial Enrollment Update; 70% of Patients Enrolled
15-Nov-13 01:04PM  OPEXA THERAPEUTICS, INC. Financials EDGAR Online Financials +13.37%
12-Nov-13 09:00AM  Opexa Therapeutics Selected as a Top 10 Advanced Therapy Projects to Watch Business Wire
06:26AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vo EDGAR Online
08-Nov-13 09:00AM  Opexa CEO Invited to Join Personalized Medicine Panel at New York CEO Conference Business Wire
07-Nov-13 04:08PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, EDGAR Online
04:08PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:05PM  Opexa Therapeutics Reports Third Quarter 2013 Financial Results and Provides Corporate Update Business Wire
06-Nov-13 09:51AM  CORRECTING and REPLACING Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results Business Wire
09:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results Business Wire
23-Oct-13 09:00AM  Opexa Therapeutics Supports National Multiple Sclerosis Society as a Corporate Sponsor of Walk MS Business Wire
21-Oct-13 09:01AM  InPlay: Opexa Therapeutics immune monitoring program featured in Neurology Reviews Briefing.com
09:00AM  Opexa Therapeutics Immune Monitoring Program Featured in Neurology Reviews Business Wire
18-Oct-13 01:01PM  Founder of St. Jude Medical to Keynote RedChip Emerging Growth Showcase on Oct. 23-24 GlobeNewswire -5.00%
17-Oct-13 11:30AM  The RedChip Money Report TV Show Now Airing Weekly on Bloomberg Europe: 139 Million Homes GlobeNewswire +8.70%
09:00AM  Opexa Therapeutics CEO to Appear on The RedChip Money Report on Fox Business News Business Wire
08-Oct-13 05:15PM  Faruqi & Faruqi, LLP Launches An Investigation Against Opexa Therapeutics, Inc. (OPXA) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors Business Wire
07-Oct-13 09:00AM  Opexa Therapeutics CEO Featured in Leading Life Science Publication Business Wire
02-Oct-13 09:00AM  Opexa Therapeutics Therapy for Multiple Sclerosis Featured in FOX Television News Story Business Wire
30-Sep-13 09:00AM  Opexa CEO Invited Panelist at 9th Annual Burrill Personalized Medicine Meeting Business Wire
Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. Its product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics was founded in 2003 and is based in The Woodlands, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Seaman Scott BDirectorDec 18Buy1.7030,00051,00040,913Dec 18 03:58 PM
Radhakrishnan KarthikChief Financial OfficerDec 18Buy1.708,00013,60058,000Dec 18 03:55 PM